Pharmafile Logo
Pharmafocus logo
Advanced Search

Gilead

Showing 4 posts of 244 posts found.

Gilead set to acquire Arresto for $225 million

December 23, 2010
Research and Development AB0024, Arresto, Cancer, Gilead, advanced solid tumours, ambrisentan, fibrotic diseases, idiopathic pulmonary fibrosis

Gilead Sciences is set to acquire fellow California, US-based biotech Arresto for $225 million to bolster its early stage pipeline. …

News

Gilead’s pill shows promise in HIV prevention

November 25, 2010
Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir

Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …

News

FDA warns Gilead over contamination risks at California facility

October 25, 2010
Manufacturing and Production AmBisome, Cayston, FDA, Gilead, Macugen, Viread, manufacturing compliance, pharma manufacturing

Gilead Sciences has been sent a warning letter from the FDA after failing to rectify problems at a facility used to …

News

Gilead is latest drugmaker in FDA’s sights

August 13, 2010
Manufacturing and Production Gilead, cystic fibrosis, manufacturing compliance

A manufacturing and distribution facility operated by US biotech Gilead Sciences is at risk of receiving a warning letter from …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025